Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 7, pp. 838-849
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, et al.
PLoS Medicine (2022) Vol. 19, Iss. 10, pp. e1003979-e1003979
Open Access | Times Cited: 39
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 29
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
Current HIV/AIDS Reports (2023) Vol. 20, Iss. 2, pp. 51-75
Open Access | Times Cited: 25
Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 212-223
Open Access | Times Cited: 31
Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort study
Line Dam Heftdal, Laura Pérez‐Alós, Rasmus Bo Hasselbalch, et al.
EBioMedicine (2023) Vol. 93, pp. 104661-104661
Open Access | Times Cited: 17
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
Vitaliy Matveev, Erik Z. Mihelic, Erika Benko, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107915-107915
Open Access | Times Cited: 15
Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART
Laura Gianserra, Maria Gabriella Donà, Eugenia Giuliani, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1243-1243
Open Access | Times Cited: 22
Booster shot of inactivated SARS‐CoV‐2 vaccine induces potent immune responses in people living with HIV
Haoting Zhan, Huixia Gao, Yongmei Liu, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles
Emma Touizer, Aljawharah Alrubayyi, Rosemarie Ford, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105862-105862
Open Access | Times Cited: 18
Reduced neutralizing antibody response to SARS‐CoV‐2 vaccine booster dose in people living with HIV with severe immunosuppression
Anaïs Corma‐Gómez, Marta Fernández‐Fuertes, Laura Viñuela, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 10
Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Living with HIV and Getting Vaccinated: A Narrative Review
Andrea De Vito, Agnese Colpani, Mattia Trunfio, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 896-896
Open Access | Times Cited: 9
Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
Luís F. López‐Cortés, Abraham Saborido-Alconchel, María Trujillo‐Rodríguez, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy
Sneha Datwani, Rebecca Kalikawe, Rachel Waterworth, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 661-661
Open Access | Times Cited: 2
Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV
Majdouline El Moussaoui, Salomé Desmecht, Aleksandr Tashkeev, et al.
Journal of Infection (2022) Vol. 85, Iss. 6, pp. 702-769
Open Access | Times Cited: 13
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
Marlou J. Jongkees, Daryl Geers, Kathryn S. Hensley, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 5, pp. 651-662
Open Access | Times Cited: 12
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
Boitumelo M. Motsoeneng, Nelia P. Manamela, Haajira Kaldine, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis
Meng-Qun Cheng, Rong Li, Zhiying Weng, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in People Living with HIV (PLWH)
Maxim Cherneha, Isabel Zydek, Peer Braß, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 785-785
Open Access | Times Cited: 1
The Impact of HIV on B Cell Compartment and Its Implications for COVID-19 Vaccinations in People with HIV
Lixing Wang, Branka Vulesevic, MariaLuisa Vigano, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1372-1372
Open Access | Times Cited: 1
Comorbidity Burden and Suboptimal Immunological Responses to Coronavirus Disease 2019 Vaccination in People Living with Human Immunodeficiency Virus
Maria Vittoria Cossu, Davide Mileto, Andrea Giacomelli, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 5, pp. 733-735
Open Access | Times Cited: 6
Immune Responses against the Omicron Variant of SARS-CoV-2 after a Third Dose of COVID-19 Vaccine in Patients Living with Human Immunodeficiency Virus (PLWH): Comparison with Healthcare Workers
Joung Ha Park, Hyemin Chung, Min‐Chul Kim, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2129-2129
Open Access | Times Cited: 6
Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
Yunyun Yi, Xiaoxu Han, Xinyu Cui, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1019-1019
Open Access | Times Cited: 3
Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China
Yuting Tan, Songjie Wu, Wei Guo, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top